Virginia Garofalo
Rome
Summary
Exceptional dermatologist with experience in lasertherapy, diagnosing skin cancer and treating a variety of skin conditions. Excel at being kind and understanding to patients when bad news needs to be delivered. Proficient in a variety of treatments, including dermatological surgery, fillers, peelings and injecting Botox safely. Able to lead a team and work with a staff who knows what they are supposed to do and is happy to do it.
Overview
9
9
years of professional experience
1
1
Certification
Work History
DERMATOLOGICAL LASER THERAPY CLINIC
Medical Doctor Dermatologist
01.2020 - Current
Professional skills with the use of fractionated LasrCo2, Pulse-Dye laser, Nd-Yag, photodynamic therapy, K Blue-laser
- Skilled at working independently and collaboratively in a team environment.
- Self-motivated, with a strong sense of personal responsibility.
Master Laser in Dermatologia
Professor
01.2023 - Current
Master Di Medicina Estetica E Del Benessere
Professor
01.2022 - Current
Master Cura Delle Onicopatie in Podologia
Professor
01.2022 - Current
Psoriasis Patient Clinic
Resident
01.2014 - 01.2019
Melanoma Patient Clinic
Resident
01.2014 - 01.2017
Education
Master of Science -
Master II Livello in Laserterapia Dermatologica
Università Degli Studi Di Roma Tor Vergata11.2022
M.D. - Dermatologist
Department of Dermatology
Università Degli Studi Di Roma Tor Vergata12.2019
M.D. - Medical School
Laurea Medicina E Chirurgia
Università Degli Studi Di Roma Tor Vergata10.2013
Skills
- Diagnose numerous types of skin problems, including melanoma, non melanoma-skin cancer , blue nevi, psoriasis, congenital nevi, and numerous other health problems
- Perform a variety of treatments, including laser treatments and refer patients to the proper medical authority when something is beyond my means to treat
- Record health backgrounds of all patients to recommend certain tests and treatments
- Conduct various cosmetic procedures, such as a chemical peel, fillers, and botulin toxin to enhance the aesthetic of a client’s skin
- Assign tasks to interns and evaluate performances regularly
Accomplishments
- Clinical Trials: Subinvestigator in: Clinical Study LP0084-1196 SITE ITA670 LEO Pharma Efficacia e sicurezza di LEO 43204 nel trattamento localizzato della cheratosi attinica sul cuoio capelluto calvo con 12 mesi di follow-up; Subinvestigator in clinical study: PER-DIC-16-001 Impact and Costs of Health Care Education, Phone Reminders and enhanced follow-up intervention on Prescription adherence, Treatment Satisfaction and Effectiveness in patients with Multiple Actinic Keratosis treated with diclofenac in hyaluronic acid gel 3% (Solaraze 3%)No-profit study; Subinvestigator in: a phase 3, multicenter, randomized, double-blind, placebo-and active comparator-controlled, parallel-group study to evaluate the efficacy and safety of bimekizumab in adults subjects with moderate to severe chronic plaque psoriasis Sponsor UCB
Certification
- Certificati Certification in English Language “OXFORD”, (University of Cambridge - First Certificate in English);June 2004
- Phase Forward Certificate in Inform GMT 5.0 CRC; June 2016
- Advanced dermatological surgery EADV 2019
Additional Information
PUBLICATIONS
Perricone R, Chimenti S, Chiricozzi A. Apremilast for the treatment of psoriasis.
Expert Opin Pharmacother. 2015;16(13):2083-94. Epub 2015 Aug 4. Review. PubMed
PMID: 26243735.
2. Chiricozzi A, Caposiena D, Garofalo V, Cannizzaro MV, Chimenti S, Saraceno R. A new therapeutic for the treatment of moderate-to-severe plaque psoriasis: apremilast. Expert Rev Clin Immunol. 2016;12(3):237-49. doi: 10.1586/1744666X.2016.1134319. PubMed PMID: 26692125. 3. Garofalo V, Saraceno R, Milana M, Lenci I, Angelico M, Orlandi A, Bianchi L. Crusted scabies in a liver transplant patient mimicking rupioid psoriasis. Eur J Dermatol. 2016 Oct 1;26(5):495-496. PubMed PMID: 27297820. 4. Puviani M, Galloni C, Marchetti S, Sergio Pavone P, Lovati S, Pistone G, Caputo V, Tilotta G, Scarcella G, Campione E, Diluvio L, Garofalo V, Bianchi L, Milani M. Efficacy of a film-forming medical device containing sunscreen (50+) and piroxicam 0.8% in actinic keratosis and field cancerization: a multicenter, assessor-blinded, 3 month trial. Curr Med Res Opin. 2017 Jul;33(7):1255-1259. doi: 10.1080/03007995.2017.1313212. Epub 2017 Apr 20. PubMed PMID: 28358282. 5. Campione E, Ventura A, Garofalo V, Torti C, Massa R, Terracciano C, Orlandi A,Bianchi L. Nodular morphea in a patient with Steinert disease. G Ital DermatolVenereol. 2019 Apr;154(2):209-210. doi: 10.23736/S0392-0488.17.05624-3. Epub 2017 Sep 8. PubMed PMID: 28895373.
6. Garofalo V, Ventura A, Mazzilli S, Diluvio L, Bianchi L, Toti L, Tisone G, Milani M, Campione E. Treatment of Multiple Actinic Keratosis and Field of Cancerization with Topical Piroxicam 0.8% and Sunscreen 50+ in Organ Transplant Recipients: A Series of 10 Cases. Case Rep Dermatol. 2017 Oct 20;9(3):211-216. doi: 10.1159/000481770. eCollection 2017 Sep-Dec. PubMed PMID: 29282394; PubMed Central PMCID: PMC5731151. 7. Cannizzaro MV, Dattola A, Garofalo V, Del Duca E, Bianchi L. Reducing the oral isotretinoin skin side effects: efficacy of 8% omega-ceramides, hydrophilic sugars, 5% niacinamide cream compound in acne patients. G Ital Dermatol Venereol. 2018 Apr;153(2):161-164. doi: 10.23736/S0392-0488.17.05742-X. PubMed PMID:29564872. 8. Spallone G, Garofalo V, Picchi E, Pitocco R, Bianchi F, Ventura A, Santoni R, Bianchi L. Prolonged survival of a patient with brain melanoma metastasis treated with BRAF and MEK inhibitors combination therapy. G Ital Dermatol Venereol. 2018 May 10. doi: 10.23736/S0392-0488.18.05990-4. [Epub ahead of print] PubMed PMID:29747484. 9. Serini SM, Cannizzaro MV, Dattola A, Garofalo V, Del Duca E, Ventura A, Milani M, Campione E, Bianchi L. The efficacy and tolerability of 5-aminolevulinic acid 5% thermosetting gel photodynamic therapy (PDT) in the treatment of mild-to-moderate acne vulgaris. A two-center, prospective assessor-blinded, proof-of-concept study. J Cosmet Dermatol. 2019 Feb;18(1):156-162. doi: 10.1111/jocd.12670. Epub 2018 May 22. PubMed PMID: 29790262. 10. Campione E, Ventura A, Diluvio L, Mazzeo M, Mazzilli S, Garofalo V, Di Prete M, Bianchi L. Current developments in pharmacotherapy for actinic keratosis. Expert Opin Pharmacother. 2018 Oct;19(15):1693-1704. doi: 10.1080/14656566.2018.1523896. Epub 2018 Oct 9. Review. PubMed PMID: 30222011. 11. Zangrilli A, Bavetta M, Mazzilli S, Garofalo V, Bianchi L. Paradoxical case effects of psoriasis following adalimumab therapy: A case series. Dermatol Ther. 2018 Nov;31(6):e12729. doi: 10.1111/dth.12729. Epub 2018 Sep 21. PubMed PMID: 30239070. 12. Mazzilli S, Garofalo V, Ventura A, Diluvio L, Milani M, Bianchi L, Campione E.Effects of topical 0.8% piroxicam and 50+ sunscreen filters on actinic keratosis in hypertensive patients treated with or without photosensitizing diuretic drugs:an observational cohort study. Clin Cosmet Investig Dermatol. 2018 Oct 12;11:485-490. doi: 10.2147/CCID.S178386. eCollection 2018. PubMed PMID:30349346; PubMed Central PMCID: PMC6188002. 13. Mazzilli S, Giunta A, Galluzzo M, Garofalo V, Campione E, Di Prete M, Orlandi A, Ardigò M, Bianchi L. Therapeutic monitoring of male genital lichen sclerosus: usefulness of reflectance confocal microscopy. G Ital Dermatol Venereol. 2019 May 14. doi: 10.23736/S0392-0488.19.06292-8. [Epub ahead of print] PubMed PMID: 31104459 14. Agozzino M, Russo T, Franceschini C, Mazzilli S, Garofalo V, Campione E, Bianchi L, Milani M, Argenziano G. Effects of topical piroxicam and sun filters in actinic keratosis evolution and field cancerization: a two-center, assessor-blinded, clinical, confocal microscopy and dermoscopy evaluation trial. Curr Med Res Opin. 2019 Oct;35(10):1785-1792. doi: 10.1080/03007995.2019.1626227.Epub 2019 Jun 13. PubMed PMID: 31148490. 15. Mazzeo M, Diluvio L, Di Prete M, Mazzilli S, Garofalo V, Coniglione F, OrlandiA, Bianchi L, Campione E. New local treatment for photoaging using a formulation containing piroxicam 0.8% and sunscreen. J Int Med Res. 2019 Jul;47(7):3127-3132.doi: 10.1177/0300060519850392. Epub 2019 Jun 6. PubMed PMID: 31167591; PubMedCentral PMCID: PMC6683937. 16. Garofalo V, Cannizzaro MV, Mazzilli S, Bianchi L, Campione E. Clinical evidence on the efficacy and tolerability of a topical medical device containing benzoylperoxide 4%, retinol 0.5%, mandelic acid 1% and lactobionic acid 1% in the treatment of mild facial acne: an open label pilot study. Clin Cosmet Investig Dermatol. 2019 May 15;12:363-369. doi: 10.2147/CCID.S182317. eCollection 2019. PubMed PMID: 31190944; PubMed Central PMCID: PMC6526677. 17. Lozzi F, Lanna C, Mazzeo M, Garofalo V, Palumbo V, Mazzilli S, Diluvio L, Terrinoni A, Bianchi L, Campione E. Investigational drugs currently in phase II clinical trials for actinic keratosis. Expert Opin Investig Drugs. 2019 Jul;28(7):629-642. doi: 10.1080/13543784.2019.1636030. Epub 2019 Jul 4. Review. PubMed PMID: 31232099. 18. Cannarozzo G, Bonciani D, Tamburi F, Mazzilli S, Garofalo V, Del Duca E, Sannino M, Zingoni T, Nisticò SP. New Insight in Noninvasive Rejuvenation: The Role of a Rhodamine-Intense Pulsed Light System. Photobiomodul Photomed Laser Surg. 2019 Sep;37(9):539-543. doi: 10.1089/photob.2019.4626. Epub 2019 Aug 5. PubMed PMID: 31381488. 19. Lozzi F, Di Raimondo C, Lanna C, Diluvio L, Mazzilli S, Garofalo V, Dika E, Dellambra E, Coniglione F, Bianchi L, Campione E. Latest Evidence Regarding the Effects of Photosensitive Drugs on the Skin: Pathogenetic Mechanisms and Clinical Manifestations. Pharmaceutics. 2020 Nov 17;12(11):1104. doi: 10.3390/pharmaceutics12111104. PMID: 33213076; PMCID: PMC7698592. 20. Cosio T, Di Prete M, Di Raimondo C, Garofalo V, Lozzi F, Lanna C, Dika E, Orlandi A, Rapanotti MC, Bianchi L, Campione E. Patidegib in Dermatology: A Current Review. Int J Mol Sci. 2021 Oct 3;22(19):10725. doi: 10.3390/ijms221910725. PMID: 34639065; PMCID: PMC8509734.Languages
Italian
Bilingual or Proficient (C2)
English
Upper intermediate (B2)
French
Intermediate (B1)
Timeline
Master Laser in Dermatologia
Professor
01.2023 - Current
Master Di Medicina Estetica E Del Benessere
Professor
01.2022 - Current
Master Cura Delle Onicopatie in Podologia
Professor
01.2022 - Current
DERMATOLOGICAL LASER THERAPY CLINIC
Medical Doctor Dermatologist
01.2020 - Current
Psoriasis Patient Clinic
Resident
01.2014 - 01.2019
Melanoma Patient Clinic
Resident
01.2014 - 01.2017
Master of Science -
Master II Livello in Laserterapia Dermatologica
M.D. - Dermatologist
Department of Dermatology
M.D. - Medical School
Laurea Medicina E Chirurgia
- Certificati Certification in English Language “OXFORD”, (University of Cambridge - First Certificate in English);June 2004
- Phase Forward Certificate in Inform GMT 5.0 CRC; June 2016
- Advanced dermatological surgery EADV 2019
Similar Profiles
Mayra Pena-MedinaMayra Pena-Medina
Call Center Specialist at Dermatologist Medical Group Of North CountyCall Center Specialist at Dermatologist Medical Group Of North County
Theresa McInallyTheresa McInally
Education Program Coordinator at University Of Calgary - Medical Doctor ProgramEducation Program Coordinator at University Of Calgary - Medical Doctor Program
CRYSTAL KYLE M GARCIACRYSTAL KYLE M GARCIA
Medical Secretary at CITY OF GENERAL TRIAS DOCTORS MEDICAL DOCTORMedical Secretary at CITY OF GENERAL TRIAS DOCTORS MEDICAL DOCTOR